आइसलैंड -
आइसलैंडी -
LYFJASTOFNUN (Icelandic Medicines Agency)
norgesic 35 mg/450 mg tafla 35+450 mg
viatris aps - orphenadrinum cítrat; paracetamolum inn - tafla - 35+450 mg
आइसलैंड -
आइसलैंडी -
LYFJASTOFNUN (Icelandic Medicines Agency)
furix tafla 40 mg
orifarm healthcare a/s - furosemidum inn - tafla - 40 mg
आइसलैंड -
आइसलैंडी -
LYFJASTOFNUN (Icelandic Medicines Agency)
furix tafla 20 mg
orifarm healthcare a/s - furosemidum inn - tafla - 20 mg
आइसलैंड -
आइसलैंडी -
LYFJASTOFNUN (Icelandic Medicines Agency)
impugan tafla 20 mg
teva b.v.* - furosemidum inn - tafla - 20 mg
आइसलैंड -
आइसलैंडी -
LYFJASTOFNUN (Icelandic Medicines Agency)
impugan dropar til inntöku, lausn 10 mg/ml
teva b.v.* - furosemidum inn - dropar til inntöku, lausn - 10 mg/ml
आइसलैंड -
आइसलैंडी -
LYFJASTOFNUN (Icelandic Medicines Agency)
impugan tafla 40 mg
teva b.v.* - furosemidum inn - tafla - 40 mg
यूरोपीय संघ -
आइसलैंडी -
EMA (European Medicines Agency)
zinplava
merck sharp & dohme b.v. - bezlotoxumab - enterocolitis, pseudomembranous - Ónæmiskerfið sera og mótefni, - zinplava er ætlað til að koma í veg fyrir endurtekna clostridium difficile sýkingu (cdi) hjá fullorðnum sem eru í mikilli hættu á að endurtekna cdi.
यूरोपीय संघ -
आइसलैंडी -
EMA (European Medicines Agency)
zynlonta
swedish orphan biovitrum ab - loncastuximab tesirine - lymphoma, large b-cell, diffuse; lymphoma, b-cell - Æxlishemjandi lyf - zynlonta as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl), after two or more lines of systemic therapy.
आइसलैंड -
आइसलैंडी -
LYFJASTOFNUN (Icelandic Medicines Agency)
risperidon krka filmuhúðuð tafla 2 mg
krka sverige ab - risperidonum inn - filmuhúðuð tafla - 2 mg
आइसलैंड -
आइसलैंडी -
LYFJASTOFNUN (Icelandic Medicines Agency)
risperidon krka filmuhúðuð tafla 0,5 mg
krka sverige ab - risperidonum inn - filmuhúðuð tafla - 0,5 mg